🇺🇸
United States · US · US:0078-0181_ad42b59d-8ad5-4855-96a9-f40c7ef4a7e3
Sandostatin
Orange BookUNIISPLATC H01CB02
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerNovartis Pharmaceuticals Corporation
CountryUS (United States)
ATC codeH01CB02
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc11007801810110 AMPULE in 1 PACKAGE (0078-0181-01) / 1 mL in 1 AMPULE (0078-0181-61)
Annotations
UNII (FDA Substance ID)
75R0U2568I
OCTREOTIDE ACETATE
RxCUI 221130
Orange Book
N019667
APAPAP
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "75R0U2568I",
"rxcui": "221130",
"inchikey": "QWFYIFWTVZFPRY-LODIGNQBSA-N",
"display_name": "OCTREOTIDE ACETATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS; SUBCUTANEOUS",
"spl_meta": {
"d0b7fe9e-7000-4b79-ba3b-291ce92c14f9": {
"match": "brand_token",
"title": "SANDOSTATIN LAR DEPOT (OCTREOTIDE ACETATE) KIT [NOVARTIS PHARMACEUTICALS CORPORATION]",
"spl_version": "29",
"published_date": "2025-12-23"
}
},
"productid": "0078-0181_ad42b59d-8ad5-4855-96a9-f40c7ef4a7e3",
"productndc": "0078-0181",
"dosage_form": "INJECTION, SOLUTION",
"orange_book": {
"appl_no": "019667",
"products": [
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "EQ 0.05MG BASE/ML",
"product_no": "001",
"approval_date": "Oct 21, 1988"
},
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "EQ 0.1MG BASE/ML",
"product_no": "002",
"approval_date": "Oct 21, 1988"
},
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "EQ 0.5MG BASE/ML",
"product_no": "003",
"approval_date": "Oct 21, 1988"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
"product_no": "004",
"approval_date": "Jun 12, 1991"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
"product_no": "005",
"approval_date": "Jun 12, 1991"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "OCTREOTIDE ACETATE",
"proprietary_name": "Sandostatin",
"active_ingred_unit": "ug/mL",
"application_number": "NDA019667",
"marketing_category": "NDA",
"nonproprietary_name": "octreotide acetate",
"start_marketing_date": "19881021",
"active_numerator_strength": "100"
}Related drugs
Other records sharing ATC code H01CB02.
- 🇺🇸BYNFEZIA PenSun Pharmaceutical Industries, Inc.
- IEEzetimibe/Simvastatin Teva Pharma 10 mg/20 mg tabletsTeva B.V.
- IEEzetimibe/Simvastatin Teva Pharma 10 mg/80 mg tabletsTeva B.V.
- 🇺🇸MycapssaChiesi USA, Inc.
- PLMycapssaAmryt Pharmaceuticals DAC
- FIMycapssaAmryt Pharmaceuticals DAC
- DKMycapssaAmryt Pharmaceuticals DAC
- 🇺🇸MycapssaAmryt Pharmaceuticals Designated Activity Company
Access this data programmatically
Query Sandostatin and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.